Literature DB >> 22101700

Salvianolic acid B inhibits the TLR4-NFκB-TNFα pathway and attenuates neonatal rat cardiomyocyte injury induced by lipopolysaccharide.

Jie Wang1, Yun Zhang, Li-li Guo, Guang-jun Wu, Rui-hua Liu.   

Abstract

OBJECTIVE: To investigate the role of the TLR4-NFκB-TNFα inflammation pathway on: lipopolysaccharide (LPS)-induced neonatal rat cardiomyocyte injury and the possible protective effects of salvianolic acid B (Sal B).
METHODS: Wistar rat (1-2 days old) cardiomyocytes were isolated and cultured. Sal B 10(-5)mol/L, 10(-6)mol/L and 10(-7)mol/L were pre-treated for 6 h in the culture medium. LPS (1 μg/mL) was added to mol/the culture medium and kept for 6 h to induce inflammation injury. The concentration of lactate dehydrogenase (LDH) in the supernatant was detected by spectrophotometry. The concentrations of tumor necrosis factor α (TNFα) and heat shock protein 70 (HSP70) in the supernatant were detected by enzyme linked immunosorbent assay. The protein expressions of toll, such as receptor 4 (TLR4) and nuclear factor kappa B (NFκB) were detected by immunohistochemistry. The mRNA expressions of TLR4 and NFκB were detected by real-realtime reverse transcription polymerase chain reaction (RT-PCR).
RESULTS: (1) The concentrations of LDH and: TNFα in the LPS control group were significantly higher than those in the control group (561.41±67.39 U/L and 77.94±15.08 pg/mL, versus 292.13±26.02 U/L and 25.39±16.53 pg/mL, respectively, P<0.01, P<0.05). Compared with the LPS control group, the concentrations of LDH and TNFα were significantly decreased in the Sal B 10(-5)mol/L pre-treated group (451.76±83.96 U/L and 34.00±10.38 pg/mL, respectively, P<0.05). (2) The TLR4 and NFκB protein expression area in the LPS control group were significantly higher than those in the control group (1712.41±410.12 μm(2) and 2378.15±175.29 μm(2), versus 418.62±24.42 μm(2) and 1721.74±202.87 μm(2), respectively, P<0.01). The TLR4 and NFκB protein expression internal optical density (IOD) values in the LPS control group were also significantly higher than those in the control group (3.06±0.33 and 7.20±1.04, versus 0.91±0.21 and 4.24±0.48, respectively, P<0.05 and P<0.01). Compared with the LPS control group, the TLR4 and NFκB protein expression areas were significantly decreased in the Sal B 10(-5)mol/L pre-treated group (1251.54±133.82 μm(2) and 1996.37±256.67 μm(2), respectively, P<0.05), the TLR4 and NFκB protein expression IOD values were also significantly decreased in the Sal B 10(-5)mol/L pre- mol/pretreated group (1.92±0.28 and 5.17±0.77, respectively, treated P<0.05). (3) The TLR4 and NFκB mRNA expressions (2(-ΔΔ)CT value) in the LPS control group were significantly higher than those in the control group (3.16±0.38 and 5.03±0.43 versus 1.04±0.19 and 1.08±0.21, respectively, P<0.01). Compared with the LPS control group, the TLR4 and NFκB mRNA expressions (2(-ΔΔ) -CT value) were significantly decreased in the Sal B 10(-5)mol/L pre- mol/pretreated group (1.34±0.22 and 1.74±0.26, respectively, treated P<0.05). The concentration of HSP70 did not show any <statistical differences in all groups (P>0.05).
CONCLUSIONS: The TLR4-NFκB-TNFα pathway was quickly activated: and was independent of HSP70 in the early phase of neonatal cardiomyocyte injury induced by LPS. The protective effects of Sal B may be through inhibiting the TLR4-NFκB-TNFα pathway and are dose-dependent.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22101700     DOI: 10.1007/s11655-011-0877-x

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  11 in total

1.  Cardiomyocyte preparation, culture, and gene transfer.

Authors:  Alexander H Maass; Massimo Buvoli
Journal:  Methods Mol Biol       Date:  2007

Review 2.  Anti-inflammatory effects of different drugs/agents with antioxidant property on endothelial expression of adhesion molecules.

Authors:  Yung-Hsiang Chen; Shing-Jong Lin; Yuh-Lien Chen; Po-Len Liu; Jaw-Wen Chen
Journal:  Cardiovasc Hematol Disord Drug Targets       Date:  2006-12

3.  The effect of salvianolic acid B combined with laminar shear stress on TNF-alpha-stimulated adhesion molecule expression in human aortic endothelial cells.

Authors:  Li Xia Xie; Siva Sundara Kumar Durairajan; Jia Hong Lu; Chen Li Liu; Wan Fung Kum; Yan Wang; Irene Koo; Wei Kang Wu; Dong Han; Fulong Lao; Jian-Dong Huang; Min Li
Journal:  Clin Hemorheol Microcirc       Date:  2010       Impact factor: 2.375

4.  TLR4 and CD14 receptors expressed in rat pineal gland trigger NFKB pathway.

Authors:  Sanseray da Silveira Cruz-Machado; Claudia Emanuele Carvalho-Sousa; Eduardo Koji Tamura; Luciana Pinato; Erika Cecon; Pedro Augusto Carlos Magno Fernandes; Maria Christina Werneck de Avellar; Zulma Silva Ferreira; Regina Pekelmann Markus
Journal:  J Pineal Res       Date:  2010-06-25       Impact factor: 13.007

5.  Anti-inflammatory activity of salvianolic acid B in microglia contributes to its neuroprotective effect.

Authors:  Shao-Xia Wang; Li-Min Hu; Xiu-Mei Gao; Hong Guo; Guan-Wei Fan
Journal:  Neurochem Res       Date:  2010-03-18       Impact factor: 3.996

6.  Salvianolic acid B protects human endothelial cells from oxidative stress damage: a possible protective role of glucose-regulated protein 78 induction.

Authors:  Hong-Li Wu; Yu-Hua Li; Yan-Hua Lin; Rui Wang; Ying-Bo Li; Lu Tie; Qian-Liu Song; De-An Guo; He-Ming Yu; Xue-Jun Li
Journal:  Cardiovasc Res       Date:  2008-09-24       Impact factor: 10.787

Review 7.  Hsp70 and cardiac surgery: molecular chaperone and inflammatory regulator with compartmentalized effects.

Authors:  Petrus R de Jong; Alvin W L Schadenberg; Nicolaas J G Jansen; Berent J Prakken
Journal:  Cell Stress Chaperones       Date:  2008-07-31       Impact factor: 3.667

8.  Activation of Rho kinase by TNF-alpha is required for JNK activation in human pulmonary microvascular endothelial cells.

Authors:  Phyllus Y Mong; Christian Petrulio; Howard L Kaufman; Qin Wang
Journal:  J Immunol       Date:  2008-01-01       Impact factor: 5.422

9.  Inhibitory effects of salvianolic acid B on the high glucose-induced mesangial proliferation via NF-kappaB-dependent pathway.

Authors:  Pei Luo; Zhenghuai Tan; Zhifeng Zhang; Honghao Li; Zhengji Mo
Journal:  Biol Pharm Bull       Date:  2008-07       Impact factor: 2.233

10.  Over-expression of calpastatin inhibits calpain activation and attenuates myocardial dysfunction during endotoxaemia.

Authors:  Xiaoping Li; Ying Li; Limei Shan; E Shen; Ruizhen Chen; Tianqing Peng
Journal:  Cardiovasc Res       Date:  2009-03-24       Impact factor: 10.787

View more
  8 in total

Review 1.  Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeutics.

Authors:  Zhuo-Ming Li; Suo-Wen Xu; Pei-Qing Liu
Journal:  Acta Pharmacol Sin       Date:  2018-04-26       Impact factor: 6.150

Review 2.  Pharmacological actions and therapeutic applications of Salvia miltiorrhiza depside salt and its active components.

Authors:  Wen-yu Wu; Yi-ping Wang
Journal:  Acta Pharmacol Sin       Date:  2012-09-03       Impact factor: 6.150

3.  Effects of Ginkgo biloba leaf extract on local renin-angiotensin system through TLR4/NF-κB pathway in cardiac myocyte.

Authors:  Hua Jiang; Peng Qu
Journal:  Exp Ther Med       Date:  2017-10-16       Impact factor: 2.447

4.  Protective effects of salvianolic acid B against hydrogen peroxide‑induced apoptosis of human umbilical vein endothelial cells and underlying mechanisms.

Authors:  Shan Gao; Shiqin Li; Qin Li; Fuyong Zhang; Mengqi Sun; Zilin Wan; Shurong Wang
Journal:  Int J Mol Med       Date:  2019-05-31       Impact factor: 4.101

5.  Salvianolic acid B attenuates the inflammatory response in atherosclerosis by regulating MAPKs/ NF-κB signaling pathways in LDLR-/- mice and RAW264.7 cells.

Authors:  Yifan Zhang; Xiaoteng Feng; Min Du; Jie Ding; Ping Liu
Journal:  Int J Immunopathol Pharmacol       Date:  2022 Jan-Dec       Impact factor: 3.298

6.  Salvianolic acid B inhibits RAW264.7 cell polarization towards the M1 phenotype by inhibiting NF-κB and Akt/mTOR pathway activation.

Authors:  Tao Zou; Shan Gao; Zhaolan Yu; Fuyong Zhang; Lan Yao; Mengyao Xu; Junxin Li; Zhigui Wu; Yilan Huang; Shurong Wang
Journal:  Sci Rep       Date:  2022-08-16       Impact factor: 4.996

7.  Cardiovascular effects of salvianolic Acid B.

Authors:  Jie Wang; Xingjiang Xiong; Bo Feng
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-10       Impact factor: 2.629

8.  Shuangshen Ningxin Capsule, a Traditional Chinese Medicinal Preparation, Alleviates Myocardial Ischemia through Autophagy Regulation.

Authors:  Jun Wang; Jincai Hou; Chengren Lin; Jianhua Fu; Jianxun Ren; Lei Li; Hao Guo; Xiao Han; Bing Wang; Jianxun Liu
Journal:  Evid Based Complement Alternat Med       Date:  2015-02-11       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.